HTBX - Possible successful vaccine-trials to lead the rally!

Heat Biologics calls itself to be proudly working to “activating the immune system”. The gp96 platform that it operates under its ownership is known to activating the human immune system to combat cancer and infectious disease. With recent pandemic going on, the companies related to healthcare and such immunity related stocks have seen a very strong upsurge. This has been because while the economic activity had stopped totally, these companies were the centre of attention for bringing up any improvements to the healthcare system. For example, HTBX went on to produce the vaccination to combat the COVID-19 and has put it to trial. With recent trials results out, the vaccinations have demonstrated Immunogenicity Proof-of-Concept in Pre-Clinical Studies. Considering these vaccinations become a success, it could be a big break-through for the company. This would lead to an excessive high demand for the products of the company and even governmental backed funding and grants.